06 August 2020
When: Thursday 6 August 2020 | 18:00 – 19:00 (BST)
Speakers: Peter Arch and Alexander Robinson
Similar to the Patent Term Extension system in the US, the Supplementary Protection Certificate (SPC) system in Europe provides extended protection for authorised pharmaceutical products beyond the normal 20 year patent term. The system can be complex to navigate, and a constantly developing body of case law has introduced additional requirements which need to be taken into account in all but the simplest of cases.
Following on from part one of this two part series, in this webinar Mathys & Squire attorneys Peter Arch and Alexander Robinson will take a closer look at controversies arising from recent case law, including whether SPCs can be granted for second medical indications, and how precisely the authorised product must be identified in a patent before being eligible for an SPC.
This event has now passed – click here to download a copy of the webinar recording.
For any queries, please contact [email protected].
Sign up to our mailing list to receive Mathys Matters, our monthly newsletter covering the latest IP news, industry insights, events and case law.
If you are interested in receiving quarterly newsletters relevant to our core sector groups - IT & engineering ('Inside Wires') and life sciences & chemistry ('Under the Microscope') - please select your preference(s) below:
Please select your practice area(s) of interest: